|
1
|
Global Asthma Network: The Global Asthma
Report 2018. http://globalasthmareport.org/Global%20Asthma%20Report%202018.pdf.
Accessed April 22, 2022.
|
|
2
|
Xiang L, Zhao J, Zheng Y, Liu H, Hong J,
Bao Y, Chen A, Deng L, Ji W, Zhong N and Shen K: Uncontrolled
asthma and its risk factors in Chinese children: A cross-sectional
observational study. J Asthma. 53:699–706. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li F, Zhou Y, Li S, Jiang F, Jin X, Yan C,
Tian Y, Zhang Y, Tong S and Shen X: Prevalence and risk factors of
childhood allergic diseases in eight metropolitan cities in China:
A multicenter study. BMC Public Health. 11(437)2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Global Initiative for Asthma: Global
strategy for asthma management and prevention (2021 update).
https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf.
Accessed April 22, 2022.
|
|
5
|
World Health Organization: World health
statistics overview 2019. https://apps.who.int/iris/bitstream/handle/10665/311696/WHO-DAD-2019.1-eng.pdf.
Accessed June 6, 2022.
|
|
6
|
Szefler SJ, Murphy K, Harper T III, Boner
A, Laki I, Engel M, El Azzi G, Moroni-Zentgraf P, Finnigan H and
Hamelmann E: A phase III randomized controlled trial of tiotropium
add-on therapy in children with severe symptomatic asthma. J
Allergy Clin Immunol. 140:1277–1287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhu K, Xiang L and Shen K: Efficacy of
Chinese Children's asthma action plan in the management of children
with asthma. Allergy Asthma Proc. 41:e3–e10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Anderson WC III and Szefler SJ: New and
future strategies to improve asthma control in children. J Allergy
Clin Immunol. 136:848–859. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Montella S, Baraldi E, Bruzzese D, Mirra
V, Di Giorgio A and Santamaria F: group of Primary Care
Pediatricians. What drives prescribing of asthma medication to
preschool wheezing children? A primary care study. Pediatr
Pulmonol. 48:1160–1170. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Belgrave DC, Buchan I, Bishop C, Lowe L,
Simpson A and Custovic A: Trajectories of lung function during
childhood. Am J Respir Crit Care Med. 189:1101–1109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lange P, Celli B, Agustí A, Boje Jensen G,
Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor
P, et al: Lung-function trajectories leading to chronic obstructive
pulmonary disease. N Engl J Med. 373:111–122. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Murray CS, Foden P, Sumner H, Shepley E,
Custovic A and Simpson A: Preventing severe asthma exacerbations in
children. A randomized trial of mite-impermeable bedcovers. Am J
Respir Crit Care Med. 196:150–158. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hamelmann E, Bernstein JA, Vandewalker M,
Moroni-Zentgraf P, Verri D, Unseld A, Engel M and Boner AL: A
randomised controlled trial of tiotropium in adolescents with
severe symptomatic asthma. Eur Respir J. 49(1601100)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kerstjens HA, Casale TB, Bleecker ER,
Meltzer EO, Pizzichini E, Schmidt O, Engel M, Bour L, Verkleij CB,
Moroni-Zentgraf P and Bateman ED: Tiotropium or salmeterol as
add-on therapy to inhaled corticosteroids for patients with
moderate symptomatic asthma: Two replicate, double-blind,
placebo-controlled, parallel-group, active-comparator, randomised
trials. Lancet Respir Med. 3:367–376. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hamelmann E, Bateman ED, Vogelberg C,
Szefler SJ, Vandewalker M, Moroni-Zentgraf P, Avis M, Unseld A,
Engel M and Boner AL: Tiotropium add-on therapy in adolescents with
moderate asthma: A 1-year randomized controlled trial. J Allergy
Clin Immunol. 138:441–450.e8. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Vogelberg C, Szefler SJ, Vrijlandt EJLE,
Boner AL, Engel M, El Azzi G, Vulcu SD, Moroni-Zentgraf PM,
Eickmeier O and Hamelmann EH: Tiotropium add-on therapy is safe and
reduces seasonal worsening in paediatric asthma patients. Eur
Respir J. 53(1801824)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rao DR, Gaffin JM, Baxi SN, Sheehan WJ,
Hoffman EB and Phipatanakul W: The utility of forced expiratory
flow between 25% and 75% of vital capacity in predicting childhood
asthma morbidity and severity. J Asthma. 49:586–592.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Szefler SJ, Goldstein S, Vogelberg C,
Bensch GW, Given J, Jugovic B, Engel M, Moroni-Zentgraf PM, Sigmund
R and Hamelmann EH: Forced expiratory flow (FEF25-75%) as a
clinical endpoint in children and adolescents with symptomatic
asthma receiving Tiotropium: A post hoc analysis. Pulm Ther.
6:151–158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kew KM, Evans DJ, Allison DE and Boyter
AC: Long-acting muscarinic antagonists (LAMA) added to inhaled
corticosteroids (ICS) versus addition of long-acting beta2-agonists
(LABA) for adults with asthma. Cochrane Database Syst Rev.
2015(CD011438)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Burgess S, Sly P and Devadason S:
Adherence with preventive medication in childhood asthma. Pulm Med.
2011(973849)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Navaratnam P, Friedman HS and Urdaneta E:
The impact of adherence and disease control on resource use and
charges in patients with mild asthma managed on inhaled
corticosteroid agents. Patient Prefer Adherence. 4:197–205.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Price D, Robertson A, Bullen K, Rand C,
Horne R and Staudinger H: Improved adherence with once-daily versus
twice-daily dosing of mometasone furoate administered via a dry
powder inhaler: A randomized open-label study. BMC Pulm Med.
10(1)2010.PubMed/NCBI View Article : Google Scholar
|
